Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Nestlé Aktie 3886335 / CH0038863350

23.07.2026 06:59:58

Press Release: Nestle: Half-year results 2026: -4-

reinforcing Nespresso's premium lifestyle proposition.

Nestlé Waters & Premium Beverages

H1-26 operating performance

-- Organic growth was 5.1%, with RIG of 1.6% and pricing of 3.5%.

-- Reported sales were CHF 1.8 billion, with a negative impact of 6.7% from

foreign exchange movements.

-- UTOP margin improved 20 bps year-on-year to 9.5%. Profitability was

driven by growth leverage and cost focus, which more than offset

increased packaging and distribution costs and currency headwinds.

Q2-26 sales performance

Growth in Nestlé Waters & Premium Beverages accelerated, led by North America, key international brands and favorable weather in Europe.

-- Organic growth was 6.6%, with RIG of 2.2% and pricing of 4.4%.

-- International brands continued to lead growth. S.Pellegrino waters

delivered high single digit growth, which was broad based across

geographies. Sanpellegrino and Maison Perrier delivered strong

double-digit growth reflecting the international expansion of Maison

Perrier and the successful rollout of premium beverages innovations.

These included Sanpellegrino's CIAO! and ZERO and Maison Perrier's new

French Kiss probiotic water. Market share gains continue in our key

international brands.

-- By market, growth was broad based, led by an acceleration in North

America. In Europe, several key markets accelerated in Q2, driven by

improved retail execution as well as favorable weather in the region.

-- By channel, growth was led by retail, which benefited from strong

category momentum, premium mix and innovation. Out-of-home also

contributed positively.

Performance by product category

H1-2026 operating performance

Water &

Total Food & Premium

Group Coffee Petcare Nutrition Snacks Beverages

Sales

H1-2026

(CHF m) 43,109 12,126 8,933 8,339 11,930 1,781

Sales

H1-2025

(CHF m) 44,228 12,016 9,229 9,082 12,077 1,824

Real

internal

growth

(RIG) 1.5% 2.9% 1.8% - 1.3% 1.9% 1.6%

Pricing 2.1% 4.7% 0.9% 0.2% 1.8% 3.5%

Organic

growth 3.6% 7.5% 2.7% - 1.2% 3.7% 5.1%

UTOP

H1-2026

(CHF m) 7,081 2,304 1,943 1,651 2,077 169

UTOP

H1-2025

(CHF m) 7,287 2,403 2,037 1,877 2,039 170

UTOP

margin

H1-2026 16.4% 19.0% 21.8% 19.8% 17.4% 9.5%

UTOP

margin

H1-2025 16.5% 20.0% 22.1% 20.7% 16.9% 9.3%

UTOP - 10 bps - 100 bps - 30 bps - 90 bps 50 bps 20 bps

margin

YoY

Q2-2026 sales performance

Waters &

Food & Premium

Total Group Coffee Petcare Nutrition Snacks Beverages

Sales

Q2-2026

(CHF m) 21,792 6,124 4,538 4,355 5,752 1,023

Sales

Q2-2025

(CHF m) 21,627 6,008 4,525 4,444 5,636 1,014

Real

internal

growth

(RIG) 1.8% 2.2% 2.0% 0.9% 1.8% 2.1%

Pricing 1.9% 3.6% 0.8% 0.7% 1.5% 4.4%

Organic

growth 3.7% 5.8% 2.8% 1.7% 3.2% 6.6%

Coffee delivered 5.8% OG in Q2, led by pricing of 3.6%, which continues to ease, along with RIG of 2.2%. All Zones contributed broadly evenly to OG. Growth was led by Nescafé, Starbucks and Nespresso, partially offset by softness in Coffee mate.

Petcare OG was 2.8% in Q2 with RIG of 2.0%. OG improved in Zone Americas and Zone AOA, and was solid in Zone Europe. Both cat and dog contributed to growth. By brand, growth was led by Pro Plan, ONE and Felix.

Nutrition OG recovered to 1.7% in Q2 after declining in Q1. The improvement was driven by reduced drag from the infant formula recall, led by a strong recovery in Zone AOA. Adult nutrition and medical nutrition reported strong results, supported by brands such as Vital Proteins and Pure Encapsulations.

Food & Snacks recorded OG of 3.2%, driven by RIG. Growth was broad-based across segments, except for frozen food, with AOA the key driver by Zone. From a brand perspective, growth continued to be driven by our global-leading billionaire brands Maggi, KitKat and Milo.

(END) Dow Jones Newswires

July 23, 2026 01:00 ET (05:00 GMT)

Passende Hebelprodukte

UBS Logo
Typ Hebel Verfall Valor
Long 7.4291 15.12.2028 151314051
Long 12.3625 15.12.2028 156216091
Long 791.2001 16.10.2026 158827680
Typ Hebel Verfall Valor
Short 10.6919 18.06.2027 158194263
Short 263.7333 18.12.2026 157036860
Typ Hebel Abstand Stop Loss Valor
Long 7.1927 12.22 156216357
Long 12.1723 6.46 157036618
Long 34.4 1.07 157975114
Typ Hebel Abstand Stop Loss Valor
Short 7.4642 11.71 157975561
Short 9.0943 9.42 159231710
Short 15.2154 5.04 157689804
Typ Faktor Abstand zum Basispreis Valor
Long 5 24.51 114086073
Long 8 -11.34 121877361
Long 12 13.22 130949945
Typ Faktor Abstand zum Basispreis Valor
In eigener Sache

Trading Signals: Ferrari: Die zweite Chance

Ferrari hat nach einer schwierigen Zeit wieder auf die Überholspur gefunden. Starke Quartalszahlen, eine angehobene Jahresprognose und ein bis 2027 gefülltes Orderbuch sprechen für weiteren Rückenwind und bieten eine neue Trading Möglichkeit.

Weiterlesen!

Analysen zu Nestlé SA (Nestle)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
05.08.26 Nestlé Buy Jefferies & Company Inc.
31.07.26 Nestlé Market-Perform Bernstein Research
27.07.26 Nestlé Neutral JP Morgan Chase & Co.
24.07.26 Nestlé Hold Deutsche Bank AG
23.07.26 Nestlé Neutral JP Morgan Chase & Co.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis

https://bxplus.ch/bx-musterportfolio/

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 15’030.62 19.97 SJYB2U
Short 15’342.53 13.95 SJZBBU
Short 15’916.15 9.00 SJB30U
SMI-Kurs: 14’449.47 12.08.2026 17:30:26
Long 13’834.28 19.43 SHBTNU
Long 13’527.01 13.82 S8B67U
Long 12’948.44 8.94 SDFBZU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com